Antitrust enforcers signal openness to divestitures and concern about HSR act compliance in the $3.3 billion UnitedHealth/Amedisys deal | McDermott Skip to main content

Antitrust enforcers signal openness to divestitures and concern about HSR act compliance in the $3.3 billion UnitedHealth/Amedisys deal

Antitrust enforcers signal openness to divestitures and concern about HSR act compliance in the $3.3 billion UnitedHealth/Amedisys deal